With any new technology, people will have questions. When vaccines were first introduced, some people were concerned that vaccines would cause harm instead of disease protection. As with any issue that involves scientific change and progress, it is important to minimize and control the risk for harm, and listen to and address concerns.
Scientists — including researchers in universities, government and companies like DuPont — all work according to a standard federal government review process that promotes safety first and foremost. Before a plant biotechnology product even enters the government review process, it is thoroughly tested and reviewed by DuPont. Let's take a quick look at the process.
Researchers at companies like DuPont convene internal meetings to review the research — before, during and after the research occurs. New biotech applications pass through a careful process of scientific review by a team of scientists who monitor research from day one.
Every country has its own standards for new food products. In the U.S., for example, the same federal regulatory agencies that oversee food, drug, agriculture and the environment all have basic safeguards for new plant biotech applications. The government reviews safety before and after the product goes to the market. » More
There also are others involved in the safety and regulation process. Through public hearings, advisory committees and other forums, regulatory agencies work with each other, industry organizations, social and environmental organizations, and consumers who are interested in participating in the process. » More
The end result is that before any biotech product becomes available, all of the research and testing on that product has been scrutinized by peers, company standards, government standards, and possibly others, to review its safety. An entire network of regulatory checkpoints guards the public and the environment. And that network and those checkpoints are constantly being reviewed as well.